Myeloma Research Group
Professor Andrew Zannettino
Andrew Zannettino is the Professor of Experimental Haematology in the Faculty of Health Sciences, University of Adelaide and heads the Myeloma Research Laboratory (MRL) and co-heads the Regenerative Medicine Program (RMP). The MRL’s efforts centre on identifying the molecular and cellular mechanisms responsible for myeloma disease progression and myeloma-associated bone loss.
The RMP stems from collaborative studies in association with Prof Stan Gronthos (Mesenchymal Stem Cell Laboratory, University of Adelaide) and Prof Paul Simmons (Mesoblast Ltd), which led to the patenting of technologies covering the identification and isolation of Mesenchymal Precursor Cells (MPC), a rare cell population present in many post-natal tissues.
A family of 7 patents surrounding this technology underpin the world’s largest cell therapy company, Mesoblast Ltd.